Anti-alcoholic and Hepatoprotective Effect of Shanxi Maojian Tea Aqueous Extract

LI Huifang; LANG Xia; CHENG Shenghui; WANG Zhishen

doi:10.13386/j.issn1002-0306.2021080205

Volume 43 Issue 10

May 2022

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(10): 372-377. > DOI: 10.13386/j.issn1002-0306.2021080205

LI Huifang, LANG Xia, CHENG Shenghui, et al. Anti-alcoholic and Hepatoprotective Effect of Shanxi Maojian Tea Aqueous Extract[J]. Science and Technology of Food Industry, 2022, 43(10): 372−377. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021080205.

Citation:

PDF (3908 KB)

Anti-alcoholic and Hepatoprotective Effect of Shanxi Maojian Tea Aqueous Extract

College of TCM and Food Engineer, Shanxi University of Traditional Chinese Medicine, Jinzhong 030619, China

More Information

Received Date: August 18, 2021
Available Online: March 18, 2022

Graphical Abstract

Abstract

Abstract

Objective: To study the anti-alcoholic and hepatoprotective effect of Shanxi Maojian tea aqueous extract, in order to provide the evidence for its further development and utilization. Methods: Kunming mice were randomly divided into 5 groups: Drunken model group, naloxone hydrochloride group (0.002 g/kg), high-dose Maojian tea group (3 g/kg), medium-dose Maojian tea group (1.5 g/kg), low-dose Maojian tea group (0.75 g/kg). Two hours after single gavage of Maojian tea by dosage of administration, each group was given the corresponding 50% alcohol (20 mL/kg), and 30 minutes after gavage with 50% alcohol, naloxone hydrochloride group was intraperitoneally injected with naloxone hydrochloride injection. The ebriety time and the sober time of drunken mice in each group were recorded. Sixty SD rats were randomly divided into 6 groups: Control group, chronic alcoholic liver injury model group, Dongbaogantai group (0.36 g/kg), Maojian tea high-dose, medium-dose and low-dose groups. Except for control group, the other groups gavage with 50% alcohol in the morning. In the afternoon, Dongbaogantai group and Maojian tea groups were given the corresponding drugs by continuous administration for 6 weeks. After the experiment, the contents of glutamate aminotransferase (ALT), aspartate aminotransferase (AST), cholesterol (TC), triglyceride (TG) in serum were detected, and the levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione (GSH) in liver were detected and pathological observation was taken after H&E staining with liver of rats. Results: Compared with the drunken model group, the sober time of Maojian tea groups were significantly shortened (P<0.01). Compared with control group, the levels of ALT, AST, TC, TG in chronic alcoholic liver injury model group were significantly increased (P<0.05), and MDA significantly increased (P<0.01), while the levels of SOD and GSH were significantly decreased (P<0.01). Compared with alcoholic liver injury group, the levels of AST, TC and MDA in Maojian tea high-dose group were significantly decreased (P<0.01), the levels of SOD and GSH were significantly increased (P<0.01), and the levels of ALT in Maojian tea medium-dose group were significantly decreased (P<0.05), AST content significantly decreased (P<0.01), SOD and GSH significantly increased (P<0.01), the levels of AST and TG in Maojian tea low-dose group were significantly decreased (P<0.01), and the levels of SOD and GSH were significantly increased (P<0.01). H&E staining results showed that the pathological changes of liver tissues in different doses of Maojian tea groups could be improved to different degrees. Conclusion: Maojian tea had anti-alcoholic and hepatoprotective effect.
- Maojian tea,
- alcoholic liver disease,
- anti-alcoholic effect,
- hepatoprotective effect

FullText(HTML)

References (31)

References

[1]	在线中国植物志[G/OL] (2021-08-15) http: //www. cn-flora. ac. cn: 28080/plantonline/plantonlinesite/toDetailPage?plantId=cf5010c3dfe94322b5b11fd0d78629f0. (Flora of China Online[G/OL]. (2021-08-15) http://www.cn-flora.ac.cn:28080/plantonline/plantonlinesite/toDetailPage?plantId=cf5010c3dfe94322b5b11fd0d78629f0.
[2]	李慧卿, 王萍. 毛建草茶叶的组分研究[J]. 山西大学学报(自然科学版),2014,37(3):410−414. [LI H Q, WANG P. Study on tea ingredients of Dracocephalum rupestre[J]. Journal of Shanxi University (Nat Sci Ed),2014,37(3):410−414. LI H Q, WANG P. Study on tea ingredients of Dracocephalum rupestre[J]. Journal of Shanxi University(Nat. Sci. Ed. ), 2014, 37(3): 410-414.
[3]	马江媛. 吕梁山脉毛建茶的功能性成分研究[D]. 太原: 山西大学, 2020 MA J Y. Study on functional ingredients of Maojian tea in the Lvliang Mountains[D]. Taiyuan: Shanxi University, 2020.
[4]	江苏新医学院编. 中药大辞典. 上册[M]. 上海: 上海人民出版社, 1977: 1347. Journal of Jiangsu New Medical College. Chinese medicine dictionary. Volume one[M]. Shanghai: Shanghai People's Publishing House, 1977: 1347.
[5]	丁聪, 李远辉, 康恒军. 岩青兰的化学成分及药理学研究[J]. 药学研究,2013,32(11):663−664. [DING C, LI Y H, KANG H J. Research review in chemical compositions and pharmacological effects of Dracocephalum rupestre Hance[J]. Journal of Pharmaceutical Research,2013,32(11):663−664. DING C, LI Y H, KANG H J. Research review in chemical compositions and pharmacological effects of Dracocephalum rupestre Hance[J]. Journal of Pharmaceutical Research, 2013, 32(11): 663-664.
[6]	KHADEM S, MARLES R J. Chromone and flavonoid alkaloids: Occurrence and bioactivity[J]. Molecules, 2012, 17(1): 191−206.
[7]	HAN X Z, REN D M, FAN P B, et al. Protective effects of naringenin-7-glucoside on doxorubicin induced apoptosis in H9C2 cells[J]. European Journal of Pharmacology,2008,581(1−2):47−53. doi: 10.1016/j.ejphar.2007.11.048
[8]	郝娜, 马伟伟, 黄航君, 等. 岩青兰化学成分及抗氧化活性[J]. 河北大学学报(自然科学版),2018,38(6):617−622. [HAO N, MA W W, HUANG H J, et al. Chemical constituents and antioxidant activity of Dracocephalum rupestre Hance[J]. Journal of Hebei University (Natrual Science Edition),2018,38(6):617−622. (HAO N, MA W W, HUANG H J, et al. Chemical constituents and antioxidant activity of Dracocephalum rupestre Hance[J]Journal of Hebei University(natrual science Edition), 2018, 38(6): 617-622.
[9]	李慧卿, 刘海美. 不同提取方法的毛建草精油抗氧化动力学研究[J]. 食品工业科技,2020,41(9):291−296. [LI H Q, LIU H M. Study on the antioxidative kinetics of essential oil of Dracocephalum rupestre Hance by different extraction methods[J]. Science and Technology of Food Industy,2020,41(9):291−296. LI H Q, LIU H M. Study on the antioxidative kinetics of essential oil of Dracocephalum rupestre Hance by different extraction Methods[J]. Science and Technology of Food Industy, 2020, 41(9): 291-296.
[10]	娄红祥, 任冬梅, 翟光喜. 一种治疗心脑血管系统疾病的总黄酮及其制备方法与应用: 中国, 02135573.8[P]. 2005-11- 23 LOU H X, REN D M, ZHAI G X. A total flavone for the treatment of cardiovascular and cerebrovascular diseases and its preparation and application: China, 02135573.8 [P]. 2005-11-23.
[11]	辛长砺, 卢耀环, 周于奋, 等. 毛建草制剂对公鸡降血脂作用的实验研究[J]. 营养学报,1995(3):343−346. [XIN C L, LU Y H, ZHOU Y F, et al. Experimental study on the effect of Maojiancao preparation on lowering blood lipid in cock[J]. Chinese Journal of Nutrition,1995(3):343−346. doi: 10.3321/j.issn:0512-7955.1995.03.010 XIN C L, LU Y H, ZHOU Y F, et al. Experimental study on the effect of Maojiancao preparation on lowering blood lipid in cock [J]. Chinese Journal of Nutrition, 1995(3): 343-346. doi: 10.3321/j.issn:0512-7955.1995.03.010
[12]	肖达民, 李丹青, 吴艳华. 酒精性肝病的中医临床研究进展[J]. 中药新药与临床药理,2018,29(1):118−122. [XIAN D M, LI D Q, WU Y H. Progress in the clinical study of Chinese medicine of alcoholic liver disease[J]. Traditional Chinese Drug Research & Clinical Pharmacology,2018,29(1):118−122. XIAN D M, LI D Q, WU Y H. Progress in the clinical study of Chinese medicine of alcoholic liver disease[J]. Traditional Chinese Drug Research & Clinical Pharmacology, 2018, 29(1): 118-122.
[13]	高斌, VIJAY H S. 酒精性肝炎新进展[J]. 临床肝胆病杂志,2019,35(3):465−468. [GAO B, VIJAY H S. What’s new in alcoholic hepatitis[J]. J Clin Hepatol,2019,35(3):465−468. doi: 10.3969/j.issn.1001-5256.2019.03.001 GAO B, VIJAY H SHAH. What’s new in Alcoholic Hepatitis[J]. J Clin Hepatol, 2019, 35(3): 465-468. doi: 10.3969/j.issn.1001-5256.2019.03.001
[14]	徐博, 吴畏难, 李传甲, 等. 萱草花总黄酮对小鼠急性酒精性肝损伤保护作用及机制探讨[J]. 中国实验方剂学杂志,2016,22(23)−139-143. [XU B, WU W N, LI C J, et al. Protection mechanism of total flavones from Hemerocallis fulva on alcohol-induced liver injury in mice[J]. Chinese Journal of Experimental Traditional Medical Formulae,2016,22(23)−139-143. (XU B, WU W N, LI C J, et al. Protection mechanism of total flavones from Hemerocallis Fulva on alcohol-induced liver injury in mice[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(23): 139-143. )
[15]	张译文, 李昱锦, 胡冰芳, 等. 三种小鼠酒精性肝病短期模型的评价[J]. 药学学报,2018,53(2):236−243. [ZHANG Y W, LI Y J, HU B F, et al. Evaluation on three short-term animal models of alcoholic liver disease[J]. Acta Pharmaceutica Sinica,2018,53(2):236−243. ZHANG Y W, LI Y J, HU B F, et al. Evaluation on three short-term animal models of alcoholic liver disease[J]. Acta Pharmaceutica Sinica, 2018, 53(2): 236-243.
[16]	ZHU C S, LIU K, WANG J L, et al. Antioxidant activities and hepatoprotective potential of Dracocephalum rupestre Hance extract against CCl₄-induced hepatotoxicity in Kunming mice[J]. Journal of Food Biochemistry,2018,42(2):12484−12489. doi: 10.1111/jfbc.12484
[17]	白美美. 连翘叶茶保肝作用研究[D]. 太原: 山西大学, 2018 BAI M M. Study on liver protective effect of Forsythia suspensa leaf tea[D]. Taiyuan: Shanxi University, 2018.
[18]	苑函. 动物醉酒实验模型的研究[D]. 北京: 中国农业大学, 2005 YUAN H. Research on experimental model of animal drunkenness[D]. Beijing: China Agricultural University, 2005.
[19]	陈丰. 枳葛解酒保肝方对大鼠酒精性肝损伤的防治作用及机制探讨[D]. 北京: 北京中医药大学, 2018 CHENG F. Effect and mechanism of Zhige Jiejiu Baogan Prescription on the prevention and treatment of alcoholic liver injury in rats[D]. Beijing: Beijing University of Chinese Medicine, 2018.
[20]	GUO Y, ZHAO Q, CAO L, et al. Hepatoprotective effect of Gan Kang Yuan against chronic liver injury induced by alcohol[J]. Journal of Ethnopharmacology,2017,208:1−7. doi: 10.1016/j.jep.2017.06.033
[21]	SONG B J, MOON K H, OLSSON N U, et al. Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids[J]. Journal of Hepatology,2008,49(2):262−273.
[22]	YAN J B, NIE Y M, LUO M M, et al. Natural compounds: A potential treatment for alcoholic liver disease?[J]. Frontiers in Pharmacology,2021,12:694475−694475. doi: 10.3389/fphar.2021.694475
[23]	吴亚, 李艳茹, 杨寄镯, 等. 酒精性肝病发病机制研究现状[J]. 临床肝胆病杂志,2020,36(12):2822−2825. [WU Y, LI Y R, YANG J Z, et al. Research advances in the pathogenesis of alcoholic liver disease[J]. J Clin Hepatol,2020,36(12):2822−2825. doi: 10.3969/j.issn.1001-5256.2020.12.038 WU Y, LI Y R, YANG J Z, et al. Research advances in the pathogenesis of alcoholic liver disease[J]. J Clin Hepatol, 2020, 36(12): 2822-2825. doi: 10.3969/j.issn.1001-5256.2020.12.038
[24]	罗安玲. 葛根、藤茶、玉米低聚肽复合组方对小鼠的解酒保肝作用研究[D]. 上海: 上海交通大学, 2019 LUO A L. Study on antialcoholic and hepatoprotective effect of compound of Pueraria, Ampelopsis grossedentata and corn oligopeptides against alcoholic liver injury in mice[D]. Shanghai: Shanghai Jiao Tong University, 2019.
[25]	LI H H, TYBURSKI J B, WANG Y W, et al. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease[J]. Alcohol Clin Exp Res,2014,38(6):1520−1531. doi: 10.1111/acer.12424
[26]	NEUMAN M G, FRENCH S W, ZAKHARI S, et al. Alcohol, micro-biome, life style influence alcohol and non-alcoholic organ damage[J]. Experimental & Molecular Pathology,2017,102(1):162−180.
[27]	TESCHKE R. Alcoholic liver disease: Current mechanistic aspects with focus on their clinical relevance[J]. Biomedicines,2019,7(3):2822−2825.
[28]	陈丰, 刘殿娜, 陈绍红, 等. 枳葛解酒保肝方对酒精性肝损伤大鼠SOD、MDA、GSH的影响[J]. 北京中医药大学学报,2018,41(4):306−309. [CHEN F, LIU D N, CHEN S H, et al. Effects of Zhige Jiejiu Baogan Fang on SOD, MDA and GSH in rats with alcoholic liver injury[J]. Journal of Beijing University of Traditional Chinese Medicine,2018,41(4):306−309. doi: 10.3969/j.issn.1006-2157.2018.04.008 CHEN F, LIU D N, CHEN S H, et al. Effects of Zhige Jiejiu Baogan Fang on SOD, MDA and GSH in rats with alcoholic liver injury[J]. Journal of Beijing University of Traditional Chinese Medicine, 2018, 41(4): 306-309. doi: 10.3969/j.issn.1006-2157.2018.04.008
[29]	中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南[J]. 中国肝脏病杂志(电子版),2010,2(4):49−53. [Fatty Liver and Alcoholic Liver Disease Group, Hepatology Society of Chinese Medical Association. Guidelines for diagnosis and treatment of alcoholic liver disease[J]. Chinese Journal of Hepatology (Electronic Edition),2010,2(4):49−53. Fatty liver and alcoholic liver disease Group, Hepatology Society of Chinese Medical Association. Guidelines for diagnosis and treatment of alcoholic liver disease [J]. Chinese Journal of Hepatology (Electronic Edition), 2010, 2(4): 49-53.
[30]	岳茜岚, 豆捷雄, 田嘉军, 等. 酒精性肝损伤啮齿类动物模型的研究进展[J]. 职业卫生与病伤,2019,34(3):193−196. [YUE Q L, DOU J X, TIAN J J, et al. Advances in research on rodent models of alcoholic liver injury[J]. Occupational Health and Damage,2019,34(3):193−196. YUE Q L, DOU J X, TIAN J J, et al. Advances in research on rodent models of alcoholic liver injury[J]. Occupational Health and Damage. 2019, 34(3): 193-196.
[31]	于纯淼, 付佳琪, 张良, 等. 食源复方解酒口服液对小鼠酒精性肝损伤的保护作用[J]. 食品工业科技,2021,42(5):300−304,310. [YU C M, FU J Q, ZHANG L, et al. Protective effect of homology of medicine and food compound alleviate a hangover oral liquid on alcoholic liver injury in mice[J]. Science and Technology of Food Industy,2021,42(5):300−304,310. YU C M, FU J Q, ZHANG L, et al. Protective effect of homology of medicine and food compound alleviate a hangover oral liquid on alcoholic liver injury in mice[J]. Science and Technology of Food Industy, 2021, 42(5): 300-304, 310.

Supplements (0)

Cited By

Cited by

Periodical cited type(4)

1.	王甜甜，孙建明，潘笑. 壳聚糖在果蔬保鲜领域的应用机理研究. 轻工科技. 2025(02): 66-68+73 .
2.	鲍佳欣，朱文卿，刘阳，李智博，张馨予，郑振佳. 低酯果胶-香菇多糖凝胶珠制备工艺优化与结构表征. 食品安全质量检测学报. 2025(06): 161-169 .
3.	郑雅露，朱圣羽，熊晓辉，薛峰，李晨. 抗菌水凝胶在食品领域的研究进展. 食品工业科技. 2023(09): 446-454 . 本站查看
4.	胡亚云，张英萍，陈琳. 多酚交联的壳聚糖水凝胶的制备及其性质研究. 当代化工研究. 2022(18): 64-66 .